Nor was there any significant correlation between serum miR-375 levels and age at diagnosis (P = 0.58) or cancer size (P = 0.92), or between serum miR-375 levels and any presence of somatic RET/RAS mutations in MTC tissue (P = 0.35). This evidence concerns the gene RET and medullary thyroid gland carcinoma.